HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

International Regulators Endorse Definition For Nanotech In Cosmetics

This article was originally published in The Rose Sheet

Executive Summary

At its fourth annual meeting July 13-15 in Toronto, members of the International Cooperation for Cosmetics Regulation endorsed a working definition for nanotechnology in cosmetics

You may also be interested in...



ICCR Accepts Four Regulatory Guidance Reports; NGOs Seek Bigger Role

Regulators from the U.S., Canada, the EU and Japan accepted reports offering guidelines for regulatory harmonization within the areas of nanotechnology, alternative test methods, trace materials and safety assessments at the fifth meeting of the International Cooperation on Cosmetic Regulation.

ICCR Accepts Four Regulatory Guidance Reports; NGOs Seek Bigger Role

Regulators from the U.S., Canada, the EU and Japan accepted reports offering guidelines for regulatory harmonization within the areas of nanotechnology, alternative test methods, trace materials and safety assessments at the fifth meeting of the International Cooperation on Cosmetic Regulation.

Nanotech Programs In U.S., EU, Move Regs Closer To Global Model

The regulation of nanotechnology continues moving towards a harmonized model as agencies on both sides of the Atlantic announce new funds and collaborations towards safety assessments.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017115

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel